Monarch Partners Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-39,973	Closed	-$452K	–	182
2022 Q1	$452K	Hold	39,973	–	–	0.1%	148
2021 Q4	$627K	Buy	+39,973	New	+$627K	0.13%	151